Bioxytran, Inc (BIXT) — 10-Q Filings

10-Q Filings (6)

• BIXT's Net Loss Narrows Amid Soaring Liabilities, Cash Up on Affiliate Loans — Nov 14, 2025 Risk: high
  BIOXYTRAN, INC. (BIXT) reported a net loss of $1,600,922 for the nine months ended September 30, 2025, a slight improvement from the $1,627,867 net loss in the
• BIOXYTRAN Reports Zero Revenue, Continues Pre-Commercial Phase — Aug 11, 2025 Risk: high
  BIOXYTRAN, INC (BIXT) reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company continues to ope
• Bioxytran, Inc. Files Q1 2025 10-Q — May 15, 2025 Risk: low
  Bioxytran, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as U.S. Rare Earth Minerals, Inc., is in the pharmaceutical pre
• BIOXYTRAN, INC. Files Q3 10-Q Report — Oct 29, 2024 Risk: low
  BIOXYTRAN, INC. filed its Q3 10-Q report on October 29, 2024, covering the period ending September 30, 2024. The company, formerly known as U.S. Rare Earth Mine
• BIOXYTRAN, INC. Files Q2 2024 10-Q — Aug 14, 2024 Risk: low
  BIOXYTRAN, INC. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as U.S. Rare Earth Minerals, Inc., is incorporated in Nevada and
• BIOXYTRAN, INC. Files 10-Q for Period Ending March 31, 2024 — Apr 19, 2024 Risk: low
  BIOXYTRAN, INC (BIXT) filed a Quarterly Report (10-Q) with the SEC on April 19, 2024. BIOXYTRAN, INC. filed a 10-Q report for the period ending March 31, 2024.

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX